BIOMAT Database Logo BIOMAT Database Logo

Combination chemotherapy with vindesine and cisplatin for refractory small cell bronchogenic carcinoma. 1986

D F Chiuten, and D T Carr, and H M Dhingra, and W K Murphy, and G Spitzer, and T Umsawasdi, and G P Bodey, and M Valdivieso

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002283 Carcinoma, Bronchogenic Malignant neoplasm arising from the epithelium of the BRONCHI. It represents a large group of epithelial lung malignancies which can be divided into two clinical groups: SMALL CELL LUNG CANCER and NON-SMALL-CELL LUNG CARCINOMA. Carcinoma, Bronchial,Bronchial Carcinoma,Bronchial Carcinomas,Bronchogenic Carcinoma,Bronchogenic Carcinomas,Carcinomas, Bronchial,Carcinomas, Bronchogenic
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy

Related Publications

D F Chiuten, and D T Carr, and H M Dhingra, and W K Murphy, and G Spitzer, and T Umsawasdi, and G P Bodey, and M Valdivieso
[Chemotherapy of advanced non-small cell bronchogenic carcinoma with cisplatin and vindesine].
August 1984, Onkologie,
D F Chiuten, and D T Carr, and H M Dhingra, and W K Murphy, and G Spitzer, and T Umsawasdi, and G P Bodey, and M Valdivieso
Cisplatin and etoposide combination chemotherapy for refractory small cell carcinoma of the lung.
May 1985, Cancer treatment reports,
D F Chiuten, and D T Carr, and H M Dhingra, and W K Murphy, and G Spitzer, and T Umsawasdi, and G P Bodey, and M Valdivieso
[Combination chemotherapy of ifosfamide, cisplatin and vindesine for non-small cell lung cancer].
May 1990, Gan to kagaku ryoho. Cancer & chemotherapy,
D F Chiuten, and D T Carr, and H M Dhingra, and W K Murphy, and G Spitzer, and T Umsawasdi, and G P Bodey, and M Valdivieso
Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.
February 1982, Cancer treatment reports,
D F Chiuten, and D T Carr, and H M Dhingra, and W K Murphy, and G Spitzer, and T Umsawasdi, and G P Bodey, and M Valdivieso
Cisplatin, vindesine, and bleomycin (DVB) combination chemotherapy for esophageal carcinoma.
January 1981, Cancer treatment reports,
D F Chiuten, and D T Carr, and H M Dhingra, and W K Murphy, and G Spitzer, and T Umsawasdi, and G P Bodey, and M Valdivieso
Cyclic alternating combination chemotherapy for small cell bronchogenic carcinoma.
February 1979, Cancer treatment reports,
D F Chiuten, and D T Carr, and H M Dhingra, and W K Murphy, and G Spitzer, and T Umsawasdi, and G P Bodey, and M Valdivieso
Combination chemotherapy with cisplatin, vindesine and mitomycin-C for advanced, inoperable non-small-cell lung cancer.
May 1992, The Medical journal of Australia,
D F Chiuten, and D T Carr, and H M Dhingra, and W K Murphy, and G Spitzer, and T Umsawasdi, and G P Bodey, and M Valdivieso
Combination chemotherapy of esophageal carcinoma using cisplatin, vindesine, and bleomycin.
March 1982, Cancer,
D F Chiuten, and D T Carr, and H M Dhingra, and W K Murphy, and G Spitzer, and T Umsawasdi, and G P Bodey, and M Valdivieso
Cisplatin, vindesine and bleomycin (CVB) combination chemotherapy of advanced non-small cell lung cancer.
March 1983, Cancer,
D F Chiuten, and D T Carr, and H M Dhingra, and W K Murphy, and G Spitzer, and T Umsawasdi, and G P Bodey, and M Valdivieso
[Chemotherapy of non-small cell bronchial cancer with ifosfamide in combination with cisplatin, etoposide or vindesine].
January 1988, Onkologie,
Copied contents to your clipboard!